news

21 Private Equity Investment and Financing Weekly Report (8.12-8.18): Inventec completed RMB 50 million in Series A financing, and Chenxin Semiconductor completed tens of millions of yuan in Series C financing

2024-08-19

한어Русский языкEnglishFrançaisIndonesianSanskrit日本語DeutschPortuguêsΕλληνικάespañolItalianoSuomalainenLatina

As the new week begins, let’s take a brief look back at the investment and financing transactions disclosed last week.

Among the newly disclosed financings in the consumer services sector, 1 financing was completed in the overseas track and 1 financing was completed in the pet track.

Among the newly disclosed financings in the pharmaceutical and health sector, 4 financings were completed in the medical device track and 4 financings were completed in the biopharmaceutical track. Xuanyu Medical completed a nearly 100 million yuan A+ round of financing, led by Guangzhou Jinkong Fund; Yutu Technology completed a tens of millions of yuan A round of financing, Taizhou Xiuzhen Medical Health Industry Investment; Huapai Bio completed a round of A financing, Sichuan-Chongqing Guanghong Fund and others participated in the investment; Shuimu Molecular completed a billion yuan angel round of financing, led by Huashan Capital.

Among the newly disclosed financings in the technology and manufacturing sectors, multiple financings were completed in the fields of artificial intelligence and advanced manufacturing. Qianxun Intelligence completed an angel round of financing of nearly 200 million yuan, led by Honghui Fund; Chenxin Semiconductor completed a C round of financing of tens of millions of yuan, with Jinding Lixin Micro Industry Fund as the sole investor.

According to incomplete statistics from 21 Ventures, there were 26 financing events in the domestic primary market from August 12 to August 18 during the reporting period. Among them, 20 financing events disclosed the financing amount and currency information, with a total scale of over hundreds of millions.


01. Multiple financings completed in the fields of technology and manufacturing

This week, artificial intelligence completed 7 financings with a total amount of hundreds of millions of RMB, far ahead of other tracks. In addition, advanced manufacturing completed 4 financings this week.


02. Beijing, Guangdong and Shanghai completed multiple financings

Judging from the geographical distribution of disclosed investment-receiving companies, this week's financing regions were mainly concentrated in Beijing, Guangdong Province, and Shanghai, which completed 5, 5, and 4 financings respectively.


03. Which investment institutions are more active?

In terms of institutional investment activity, Yunze Capital was relatively active this week, completing two financings, mainly in the fields of advanced manufacturing and production manufacturing.


The following is a summary of investment and financing information: Consumer Services

Infanti completed RMB 50 million A+ round of financing

On August 14, Infanti, a short-distance travel company, received RMB 50 million in A+ round of financing from industry insiders. The funds will be used to increase production capacity, build overseas channels and invest in overseas marketing.

Infanti was founded in 2012, and its products range from electric balance bikes, eScooters (electric scooters) to the currently popular E-bike (electric-assisted bicycle). In the same year of its establishment, Infanti became the only electric unicycle brand with independent patents in the domestic market at that time and the exclusive general operator of SOLOWHEEL in the Asia-Pacific region. In 2014, Infanti began to enter the scooter and balance bike market, and reached a strategic cooperation with Lenovo to successively launch the balance bike N4, scooter M1Plus, M2 series, etc. Among them, M1Plus won the 2021 German iF Design Award. In 2021, Infanti established the "Five-Wheel Travel" brand and cooperated with Huawei Hongmeng Zhilian to launch the D1 electric-assisted bicycle for fitness and travel.

Drawing Geometry completes tens of millions of yuan in Pre-A+ round of financing, with Ventech China participating in the investment

On August 16, Huafa Geometry, a manufacturer of the Xiaochong smart ecosystem, received tens of millions of yuan in Pre-A round of financing. The investor was Ventech China, and Light Chasing Capital served as the exclusive financial advisor.

This round of financing will be used for product and market expansion. Huafa Geometry was founded in 2015 and is a manufacturer focusing on small pet smart home appliances. The Mijia smart fish tank, which is exclusively cooperated with Xiaomi, has sold 800,000 units, ranking first in the domestic smart fish tank category.


Healthcare

Xuanyu Medical completed nearly 100 million yuan in A+ round of financing, led by Guangzhou Financial Holding Fund

On August 12, Shanghai Xuanyu Medical completed nearly 100 million yuan in A+ round of financing. This round of financing was led by Guangzhou Jinkong Fund, and participated by Zhuopu Capital, Jinxin Capital, Zhangjiagang Industrial Capital and other institutions. The old shareholder Xingzheng Capital continued to provide support. This round of funds will be mainly used for the company's commercial team building, accelerated operation of production bases and product pipeline research and development, to create a differentiated design of cardiac electrophysiology and peripheral vascular intervention product matrix.

Founded in 2020, Xuanyu Medical is committed to providing innovative clinical solutions based on its three major technology platforms: active devices, interventional catheters, and biomaterials. Its independently developed products include cardiac pulsed field ablation system (PFA) and venous closure system, etc., and are expected to enter the commercial verification stage by the end of 2024.

Xirun Medical completed tens of millions of yuan in Pre-A financing, with Ningbo Fuchuang Venture Capital Fund and Ningbo Angel Fund jointly investing

On August 13, Ningbo Xirun Medical Technology Co., Ltd. (hereinafter referred to as "Xirun Medical"), a soft rehabilitation robot company, announced that it had completed tens of millions of yuan in Pre-A round of financing. This round of financing was jointly invested by Ningbo Fuchuang Venture Capital Fund and Ningbo Angel Fund.

Since its establishment in 2019, Xirun Medical has been deeply engaged in the field of rehabilitation technology. Relying on the rehabilitation robot transformation platform of Shanghai Jiaotong University, it is committed to the research and development of rehabilitation robot technology and the creation of a series of soft rehabilitation robot products to help patients recover better, improve their quality of life, and give patients a new life. The company's products have more than 40 patents and have obtained domestic NMPA, EU CE, and US FDA medical device registration certificates.

Yutu Technology completed a round A financing of tens of millions of yuan, and Taizhou Xiuzhen Medical Health Industry Investment

On August 12, Yutu Technology announced that it had completed a tens of millions of yuan in round A financing. This round of financing was invested by Taizhou Xiuzhen Medical Health Industry Investment, which will further strengthen the company's dominant position in the field of transformation of medical research results.

Founded in 2021, Yutu Technology is a CXO service provider focusing on full-process professional services for medical device clinical trials and registration (CRO), custom contract manufacturing outsourcing (CDMO), and sales outsourcing (CSO). It provides comprehensive one-stop solutions for global medical device companies including R&D transformation, system construction, contract manufacturing, clinical trials, registration declaration, sales promotion, etc., reducing the risks of late R&D, production and sales, shortening the product launch cycle, saving clinical trial and market sales costs, and promoting the product marketization process.

Huapai Biopharma Completes Series A Financing, Sichuan-Chongqing Guanghong Fund and Others Participate in the Investment

On August 14, Huapai Biotechnology (Group) Co., Ltd. (hereinafter referred to as "Huapai Biotechnology") completed its first round of financing. Sichuan-Yu Guanghong Fund under Guosen Hongsheng, a well-known industry party, Jinmu Capital and others participated in the investment. Kaicheng Capital served as the exclusive financial advisor.

Founded in 2008, Huapai Bio is a group-based animal health enterprise that focuses on the research and development, production, sales and technical services of animal health products such as veterinary biological vaccines, antibodies, diagnostic reagents, and veterinary drugs. It has decades of industry experience. The group has successively built high-standard Huapai Group Headquarters, Chongqing Aolong, Chongqing Yongjian, Tengchong Huayu, Zhuji Gaoling, five veterinary biological product production bases, and Chengdu Jinghua Pharmaceutical Production Base.

Danbo Pharmaceuticals completed a RMB 10 million angel round of financing, led by Hong Kong Guihe Capital

On August 14, Shanghai Danbo Pharmaceutical completed a 10 million yuan angel round of financing, led by Hong Kong Guihe Capital. This financing not only marks an important milestone for Danbo Pharmaceutical in the capital market, but also lays a solid foundation for its further expansion and deepening in the Greater China market.

Founded in 2024, Tanba Pharmaceutical is a dietary supplement developer and manufacturer, and a subsidiary of Showa Corporation of Japan. The company operates several health food brands in Greater China, including "Tamba Kanrai", "Azuchi Momoyama", and "Huangfang".

Shuimu Molecule completed 100 million yuan angel round financing, led by Huashan Capital

On August 14, it was reported that the biopharmaceutical large model company "Shuimu Molecule" completed a RMB 100 million angel round of financing, led by Huashan Capital, with participation from Daotong Investment and iFlytek Venture Capital.

Shuimu Molecular was incubated and established by the Institute of Intelligent Industry (AIR) of Tsinghua University in 2023. It is mainly engaged in basic large-scale model research in the biopharmaceutical industry and has developed a conversational drug development assistant tool ChatDD. Professor Guoqiang of Tsinghua University and Chief Researcher of AIR Nie Zaiqing serves as the company's chief scientist

Meiliu Biotech Completes Strategic Financing, Shenzhen Institutes of Advanced Technology as Exclusive Investor

On August 15, Hangzhou Meiliu Biotech completed strategic financing, exclusively invested by Shenzhen Institute of Advanced Technology. After this round of financing, Shenzhen Institute of Advanced Technology will support Meiliu Biotech to explore the medical beauty market in the fields of recombinant collagen and synthetic biology materials innovation, and provide strategic support. On the other hand, Meiliu Biotech will assist Shenzhen Institute of Advanced Technology in completing the transformation of scientific and technological achievements.

Founded in 2023, Meiliu Bio focuses on the research and development of bioactive substances, intermediates, and health products of microbial origin. It is a synthetic biology company driven by technological innovation, combined with market demand, and with industrialization capabilities.

HiMed Medical Completes Series A Financing, IDG Capital Leads Investment

On August 16, Humatrix Medical (Suzhou) Co., Ltd. (hereinafter referred to as "Humatrix Medical") announced the completion of its Series A financing. This round of financing was led by IDG Capital, and old shareholders Shanghai Biomedicine Innovation Transformation Fund and Huafang Capital followed suit. This round of funds will be mainly used to promote the clinical trials of the company's core product, small-caliber artificial blood vessels.

Founded in 2021, HiMed Medical is committed to building a leading tissue engineering and regenerative medicine technology platform. The company focuses on the development and production of small-caliber tissue-engineered blood vessels, which are suitable for the establishment of dialysis vascular access for chronic renal failure, vascular replacement for lower limb arterial trauma, lower limb atherosclerosis and coronary artery bypass grafting for coronary heart disease. Based on this technology platform, the company plans to develop and produce other regenerative medicine products, and conduct global clinical research and commercialization to meet the growing and far-from-met clinical needs.

Jiuzhi Technology RingConn received tens of millions of yuan in angel + round financing

On August 16, Jiuzhi Technology recently completed an angel+ round of financing of tens of millions of RMB. Investors include Professor Gao Bingqiang and his Brizan Ventures II Fund and Future Technology Fund, Professor Li Zexiang's Clearwater Bay Fund and HKX Fund, and Professor Gan Jie's Virtu International Limited. This round of financing will be used for R&D, market and team expansion.

Jiuzhi Technology was founded in July 2021 by Professor Wang Guoxing, a distinguished professor at Shanghai Jiao Tong University, and Dr. Wu Hao, an artificial intelligence expert. It has independent intellectual property rights in core technologies such as low-power biological signal acquisition systems, bioinformation sensors, and artificial intelligence algorithms.


Technology and Manufacturing

Funshine Sales completes US$75 million strategic financing, led by Eastern Bell Capital

On August 12, CRM company Funshine announced that it had completed a new round of strategic investment of US$75 million, led by Eastern Bell Capital, followed by Qiming Venture Partners and Jianfa New Investment, and Gaogu Capital served as the exclusive financial advisor. This is the second time Funshine has received investment in a year after receiving US$30 million from Guiyang Venture Capital in July 2023. This is also the fourth consecutive year that it has received new investment, and it has set a record for the largest financing transaction in the domestic SaaS industry in the past two years.

Fenxiang Sales was founded in 2008. After this round of financing, Fenxiang Sales will continue to improve its product platform, integration, industry and upstream and downstream business connection capabilities, strengthen internationalization and AI capability building, and accelerate the evolution of business-based CRM to intelligent CRM.

Qianxun Intelligence completed nearly 200 million yuan in angel round financing, led by Honghui Fund

On August 12, it was reported that Qianxun Intelligent, an embodied intelligent robot company, completed a seed round and angel round financing of nearly 200 million yuan. The angel round financing was led by Honghui Fund, followed by Dachen and Qiancheng, and seed round investors Shunwei Capital and Oasis Capital continued to follow up. The funds raised in this round of financing will be mainly used for technology research and development and team expansion.

Qianxun Intelligent Manufacturing was established in February 2024. In the six months since its establishment, the company completed two rounds of financing in just four months.

ZhuoShi Technology Completes RMB100 Million B+ Round of Financing, Shenzhen Tongchuang Weiye Leads the Investment

On August 12, ZhuoShi Technology, an artificial intelligence large model company, completed a B+ round of financing of 100 million yuan. The financing was led by the well-known investment institution Shenzhen Tongchuang Weiye, and followed by Qingdao state-owned asset platform Qingdao Haifa and TusStar and other institutions.

ZhuoShi Technology was founded in Beijing in 2019. Tu Jing, a former executive of Baidu Maps and Baidu APP, is the founder of the company. The founding team and core members mainly come from large companies such as Baidu and Lenovo. Currently, ZhuoShi Technology has established cooperation with governments in many places across the country and established three R&D centers in Beijing, Chengdu and Hainan, which are responsible for R&D operations, AI R&D and data services respectively.

Hengzhi Future received tens of millions of yuan in financing, led by Qingshui Bay Phase II Fund

On August 12, Hengzhi Future (Chongqing) Innovation Technology Co., Ltd. (hereinafter referred to as "Hengzhi Future"), a robotics company formed by a post-95 entrepreneurial team, announced the completion of a round of RMB 10 million financing. The financing was led by the Clearwater Bay Phase II Fund under Professor Li Zexiang's XbotPark Robot Base, followed by Hong Kong X Technology Fund (HKX Fund), Professor Gao Bingqiang and his affiliates, Professor Gan Jie's Zhixing No. 1 Fund, and Huaye Tiancheng. The funds will be mainly used for product research and development, market expansion, and team building.

Hengzhi Future was founded in 2022. Its first product, SPARKY, will be officially launched in the market at the end of 2024. Previously, SPARKY has received high praise at many exhibitions. The company plans to showcase its latest version at the World Robot Conference from August 21 to August 25, 2024.

Chengxin Intelligence completes a round of financing of tens of millions of yuan, led by Frees Capital

On August 12, Chengxin Intelligence announced that it had completed a round A financing of tens of millions of RMB. This round of investment was led by Frees Capital, and old shareholder Oufang Angel followed suit. Chengxin Intelligence had previously received investments from Tang's (China) Investment, Spinel Capital and other institutions. The funds raised in this round will be used to strengthen the construction of data set construction services and intelligent data engineering platforms, recruit a world-class talent team, and accelerate the company's product and business layout in the global market.

Integer Intelligence was founded in 2021. It is a data company dedicated to providing data service support for artificial intelligence. Its business covers many fields such as intelligent driving (Automobile AI), generative AI (Generative AI), embodied AI, etc. The current team size of the company is less than 100 people.

Chenxin Semiconductor completed a C round of financing of tens of millions of yuan, with Jinding Lixin Micro Industry Fund as the sole investor

On August 13, power management chip design company Chenxin Semiconductor (Shenzhen) Co., Ltd. received tens of millions of yuan in Series C financing, which was exclusively invested by a fund jointly established by Jinding Capital and Lixin Micro. The financing funds will be used to accelerate the company's new product research and development, product mass production and market expansion.

Founded in 2017, Chenxin Semiconductor is a high-tech company specializing in the research and development of power management and battery management chips. Its main products are battery management products such as switch fast charging and charge pump chips.

DeepBlue Aerospace completes B3 round of financing, with investment from Zhengyue Investment and Zhenghe Yunfan Fund

On August 13, the domestic commercial aerospace company Deep Blue Aerospace completed the B3 round of strategic financing, which was funded by Zhenghe Yunfan Fund established by Zhengyue Investment. After completing this round of financing, Deep Blue Aerospace will set up its international business and service headquarters in Jimei District, Xiamen. So far, Deep Blue Aerospace has completed three rounds of financing in less than three months and has been recognized by many state-owned institutions. The B2 round of financing took place only half a month ago, led by Wuxi High-tech Zone Investment and Control Group, and completed the fixed capital of nearly 1 billion yuan. The B1 round was funded by Jigang Dongtai Fund and others.

Founded at the end of 2016, the company is a commercial aerospace enterprise whose core business is the research and development, production of launch vehicles and provision of commercial launch services. It has always focused on the development of liquid reusable launch vehicles, and is committed to significantly enhancing humans' ability to enter space and reducing the cost of entering space.

Huanxin Yilian completes tens of millions of Pre-A round of financing, with Yunze Capital as the sole investor

On August 13, aerospace optical communication company Huanxin Yilian (Shanghai) Technology Co., Ltd. (hereinafter referred to as "Huanxin Yilian") recently completed tens of millions of yuan in pre-A round of financing, exclusively invested by Yunze Capital. The funds from this round of financing will mainly be used for Huanxin Yilian's R&D investment and capacity construction.

Huanxin Yilian is a technology-based company integrating industry, academia and research, focusing on the research and development, production and sales of aerospace laser communication products. Its core products, aerospace-grade fiber amplifiers and narrow-linewidth lasers, have been adapted to mainstream satellite-borne laser terminal manufacturers. The company's R&D team is composed of core talents from leading technology companies such as China Electronics Technology Group Corporation, II-VI, nLight, and Aerospace Science and Technology, and has deep technical accumulation in the fields of optical fiber communication, space lasers, electronic information, etc. At the same time, the team has complementary advantages in the military and civilian dual-use fields. It has both technical personnel familiar with military scenarios such as military industry, aerospace, and ocean, and technical personnel who are good at civilian optical fiber communication applications and automated mass production experience.

Sodry completed a round A financing of over 100 million yuan, with joint investment from Jiangxia Green Fund and Xingxiang Capital's Technology Achievement Transformation Fund

On August 14, Shenzhen Solid New Materials Technology Co., Ltd. (hereinafter referred to as "Solid") has completed a round A financing of several hundred million yuan. This round of financing was jointly invested by Jiangxia Green Fund under Three Gorges Capital and Technology Achievement Transformation Fund of Xingxiang Capital, and old shareholders Donghai Investment Control and CITIC Construction Investment Capital continued to invest. The funds raised will be mainly used for the research and development of high-performance lithium battery new materials, production line construction, and replenishment of working capital.

Founded in November 2019, Solid is a high-tech enterprise specializing in the research and development, production, application and sales of silicon-based anode materials and solid electrolyte core materials. The company focuses on the research and development, production and sales of solid-state battery core materials. Its main products and technologies include new lithium battery materials such as silicon-carbon anode materials and solid electrolyte materials.

Tilburg completes tens of millions of yuan in Pre-A round of financing, led by Oriza Puhua

On August 15, Dierboger (Shenzhen) Intelligent Technology Co., Ltd. (hereinafter referred to as "Dierboger") recently completed a Pre-A round of financing of tens of millions of yuan, led by Yuanhe Puhua, followed by Donghai Investment Control, and Xinpai Capital served as the financial advisor for this round. The financing funds will be used for iterative development of technology and products, market expansion, etc.

Founded in 2022, Tierburg is a company that focuses on intelligent robots in the heavy industry and provides customers with flexible robot process stations. The core team members graduated from Tsinghua University, Xi'an Jiaotong University, Xidian University and other universities, and have worked in well-known domestic nuclear power research institutes and robotics research institutes. They have deep technical research and development accumulation and industrial implementation experience in the fields of heavy industry and robotics.

Luying Technology Completes Angel Round Financing, BlueRun Ventures and Redpoint China Participate in Investment

On August 15, AI video generation technology company Avolution.ai completed its angel round of financing, with participation from BlueRun Ventures and Redpoint China. At the same time, Avolution.ai is launching a new round of financing, and the proceeds will be mainly used for technology and product investment, as well as team building.

Luying Technology was founded in September 2023 and positions its product as a bilateral platform for AI creation and content consumption of anime images and videos.

Acori Measurement & Control completes tens of millions of yuan in Pre-A round of financing, with Yunze Capital as the sole investor

On August 15, Shanghai Acori announced that it had completed tens of millions of yuan in pre-A round of financing, exclusively invested by Yunze Capital. The funds from this round of financing will be mainly used for the company's capacity construction, R&D investment and personnel expansion.

Founded in 2022, Acori is a company that focuses on the research, development, production and sales of mid-to-high-end Coriolis mass flowmeters. Its product line covers conventional working conditions as well as special application scenarios such as cryogenic, high temperature, high pressure, corrosion resistance, and sanitary grade.

Tongchao Precision completed its Series A financing, with participation from Bangsheng Capital, Camel Equity Investment and others

On August 16, Wuhu Tongchao Precision Machinery Co., Ltd. (referred to as "Tongchao Precision") successfully completed new financing. New investors include a certain industry party, Bangsheng Capital, Camel Equity Investment, Guoyuan Innovation, Guoyuan Fund, Hefei Construction Investment Capital, Guohe Investment and other institutions.

Tongchao Precision was established in March 2016 and is engaged in new product manufacturing and surface treatment of core components (upper and lower electrodes, heaters) of display panels and key integrated circuit equipment, covering metal parts, high-purity silicon parts, quartz parts, etc.

Dingneng Optoelectronics completed nearly 100 million yuan in angel round financing, with Envision Sequoia Carbon Neutrality Fund and Envision Venture Capital jointly investing

On August 16, Hangzhou Dingneng Optoelectronics Technology Co., Ltd. announced that it has completed nearly 100 million yuan in angel round financing, which was jointly invested by Envision Sequoia Carbon Neutrality Fund and Envision Venture Capital. After the completion of this round of financing, the funds will be mainly used to expand the R&D team, speed up R&D, and continuously upgrade and iterate MW/GW-level perovskite mass production line solutions.

The company was established in 2023. According to reports, Dingneng Optoelectronics' Hangzhou perovskite complete line laboratory was officially put into use in July 2024, and is gradually building an open platform for the perovskite test line.

INAIR Completes Millions of Dollars in Angel+ Round Financing

On August 16, domestic AR glasses manufacturer Multiscreen Future announced that it had completed a new round of financing of several million dollars.

Multiscreen Future was founded in 2022 and was co-founded and incubated by Zhenzhi Ventures. The core team has rich experience in the XR industry, and team members come from many well-known companies in the Internet and technology fields. Multiscreen Future previously released the new product INAIR2, which is the first AR spatial computer in China, creating a new era of AR technology.